Brief: Modus Therapeutics Q3 Loss After Tax Widens To SEK 4.4 Mln
Nov 18 (Reuters) - Modus Therapeutics Holding AB MODTX.ST :
* MODUS THERAPEUTICS PUBLISHES INTERIM REPORT FOR THE THIRD
QUARTER 2021
* Q3 LOSS AFTER TAX AMOUNTED TO TSEK 4 441 (697)
* Q3 LOSS PER SHARE AMOUNTED TO SEK 0,30 (0,12)
* Q3 CASH FLOW FROM CURRENT OPERATIONS WAS NEGATIVE IN
AMOUNT OF
TSEK 4 226 (942)
Source text for Eikon: ID:nWkr7vYZNF
Further company coverage: MODTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million